CID 165918349

2-{6-[(morpholin-4-yl)methyl]-1h-1,3-benzodiazol-2-yl}ethan-1-amine trihydrochloride

Structural Information

Molecular Formula
C14H20N4O
SMILES
C1COCCN1CC2=CC3=C(C=C2)N=C(N3)CCN
InChI
InChI=1S/C14H20N4O/c15-4-3-14-16-12-2-1-11(9-13(12)17-14)10-18-5-7-19-8-6-18/h1-2,9H,3-8,10,15H2,(H,16,17)
InChIKey
OGVCPWVCNLFJAK-UHFFFAOYSA-N
Compound name
2-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]ethanamine
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

0
Patents

260.1637 Da
Monoisotopic Mass

0.3
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 261.17098 161.0
[M+Na]+ 283.15292 172.9
[M+NH4]+ 278.19752 168.2
[M+K]+ 299.12686 168.3
[M-H]- 259.15642 164.8
[M+Na-2H]- 281.13837 166.1
[M]+ 260.16315 163.5
[M]- 260.16425 163.5
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

No patent data available for this compound.